Home › Hemophilia › Michigan › Ann Arbor
Hemophilia clinical trials in Ann Arbor, MI
4 studies for Hemophilia are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
RecruitingPhase 3
- University of Michigan - 1500 E Medical Center Dr, Ann Arbor
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RecruitingPhase 3
- University of Michigan Health System - Ann Arbor- Site Number : 8400003, Ann Arbor
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
RecruitingPhase 1Healthy volunteers welcome
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
RecruitingPhase 1
- University of Michigan Medical School, Ann Arbor
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN9 studies
- Seattle, WA8 studies
- Cedar Rapids, IA7 studies
- Los Angeles, CA6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Little Rock, AR5 studies
- San Antonio, TX5 studies
- Sacramento, CA5 studies
- Orange, CA4 studies
- Tampa, FL4 studies
- St. Louis, MO4 studies
Other studies in Ann Arbor
- Prostate Cancer26 studies
- Cancer (all types)25 studies
- Breast Cancer25 studies
- Lung Cancer23 studies
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease15 studies
- Pancreatic Cancer14 studies
- Multiple Myeloma13 studies
- Atrial Fibrillation12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.